O6-Benzylguanine-mediated enhancement of nitrosourea activity in Mer− central nervous system tumor xenografts – implications for clinical trials Stephen T. KeirM. Eileen DolanHenry S. Friedman ORIGINAL ARTICLE Pages: 437 - 440
Induction of oocyte maturation by jun-N-terminal kinase (JNK) on the oncogenic ras-p21 pathway is dependent on the raf-MEK-MAP kinase signal transduction pathway L. ChieS. AmarM. R. Pincus ORIGINAL ARTICLE Pages: 441 - 449
A comparison of the effects of nine folate analogs on early and late murine hematopoietic progenitor cells in vitro Astrid StrømhaugDavid J. Warren ORIGINAL ARTICLE Pages: 450 - 456
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer M. O. NicolettoR. PadriniA. Corsini ORIGINAL ARTICLE Pages: 457 - 462
The pharmacokinetics of a 1-h paclitaxel infusion K. MrossN. HolländerH. Maier-Lenz ORIGINAL ARTICLE Pages: 463 - 470
In vitro synergistic effects of vinflunine, a novel fluorinated vinca alkaloid, in combination with other anticancer drugs Jean-Marc BarretChantal EtiévantBridget T. Hill ORIGINAL ARTICLE Pages: 471 - 476
Dihydropyrimidine dehydrogenase activity in normal, inflammatory and tumour tissues of colon and liver in humans Rosine GuimbaudSylvie GuichardPierre Canal ORIGINAL ARTICLE Pages: 477 - 482
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer Ralf Axel HilgerGabriele JacekMax Ernst Scheulen ORIGINAL ARTICLE Pages: 483 - 488
Development of a schedule-dependent population pharmacodynamic model for rhizoxin without quantitation of plasma concentrations Boon C. GohGini F. FlemingMark J. Ratain ORIGINAL ARTICLE Pages: 489 - 494
The pharmacokinetics of liposomal encapsulated daunorubicin are not modified by HAART in patients with HIV-associated Kaposi's sarcoma Luca FumagalliMassimo ZucchettiAdriano Lazzarin ORIGINAL ARTICLE Pages: 495 - 501
New chemotherapeutics in malignant mesothelioma: effects on cell growth and IL-6 production Blair R. McLarenBruce W. S. RobinsonRichard A. Lake ORIGINAL ARTICLE Pages: 502 - 508
A phase II study of temozolomide in hormone-refractory prostate cancer Jérôme P. van BrusselMartijn B. BusstraGerald H. Mickisch CLINICAL TRIAL REPORT Pages: 509 - 512
Ifosfamide and vinorelbine in advanced pretreated ovarian cancer: a phase II study Mario NardiSalvatore De MarcoFrancesco Cognetti CLINICAL TRIAL REPORT Pages: 513 - 515